Asia Pacific Organoids Market Forecast to 2027: Amalgamation of Organ-on-Chip with Organoids to be a Prevalent Trend – ResearchAndMarkets.com

Asia Pacific Organoids Market Forecast to 2027: Amalgamation of Organ-on-Chip with Organoids to be a Prevalent Trend – ResearchAndMarkets.com




Asia Pacific Organoids Market Forecast to 2027: Amalgamation of Organ-on-Chip with Organoids to be a Prevalent Trend – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Organoids Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type; Application; Source, and Country” report has been added to ResearchAndMarkets.com’s offering.

Amalgamation of Organ-on-Chip with Organoids to be a Prevalent Trend in the Organoids Market

‘Asia-Pacific Organoids Market is expected to reach US$ 513.74 Mn in 2027 from US$ 97.02 Mn in 2019. The market is estimated to grow with a CAGR of 23.1% from 2020-2027.

Organoid and organ-on-a-chip, which are served as evolving pathological and human physiological relevant in vitro models, hold an excessive potential to revolutionize the conventional example in basic and clinical research.

The recent inclination in the collaborative application of organoid with organ-on-a-chip and 3D bio printing enables development of sophisticated cancer models to study underlying mechanisms of tumour-stroma interactions, multi-organ tumour metastasis, and cancer-microenvironment interactions.

By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit both organoid and organ-on-a-chip benefits and provides a useful tool to study multi-organ tumour metastases and cancer-microenvironment interactions. Overall, researchers expect that these emerging in vitro cancer model systems will ultimately revolutionize the conventional paradigm of cancer research and produce real clinical benefits.

Key driving factor such as rising adoption of bio-banking and tumour modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the market. However, lack of expertise is likely to have a negative impact on the growth of the market in the coming years.

Companies Mentioned

  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • STEMCELL Technologies Inc
  • Organoid Therapeutics
  • Corning Incorporated

Scope of the Report

Asia-Pacific Organoids Market- By Type

  • Stomach
  • Intestine
  • Liver
  • Pancreas
  • Lung
  • Brain
  • Kidney
  • Others

Asia-Pacific Organoids Market- By Application

  • Developmental Biology
  • Disease Pathology of Infectious Disease
  • Regenerative Medicine
  • Drug Toxicity and Efficacy Testing
  • Drug Discovery and Personalized Medicine
  • Others

Asia-Pacific Organoids Market – By End User

  • Pluripotent Stem Cells
  • Organ-specific Adult Stem Cells

For more information about this report visit https://www.researchandmarkets.com/r/ogl7ti

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900